All Articles

With its Felix AI assistant, Syncx is accelerating locums staffing with faster placements and risk assessment to combat a critical healthcare shortage.

Following massive asset sales and billions in dividends, Array Digital reports surging tower revenue and an optimistic forecast for its new 5G future.

Cricket icon Rahul Dravid and Colgate Total are reframing oral care from simple hygiene to a critical performance ritual backed by compelling science.

As demand for data centers and electrification soars, nVent brings in veteran Mellinda Devese to transform its global supply chain and secure future growth.

As a historic cold snap gripped New York, renewable diesel kept essential city services running, proving its reliability in the most extreme conditions.

After selling its wireless unit, TDS reports soaring profits and announces aggressive new growth targets for its fiber broadband and tower businesses.

With a new finance chair and a renewed pact with an activist investor, the off-price retailer is doubling down on its modernization and growth strategy.

Stunning high-grade gold samples, including one at 250 g/t, prompt Yukon Metals to consolidate a historic mining area near Whitehorse.

As Ranger Energy Services prepares to release its Q4 results, investors are watching closely after a tough Q3. Will the report signal recovery or continued pain?

Bitdeer leverages complex financial deals to refinance debt and fund a major expansion into the booming AI and high-performance computing market.

Pakistan launches its ambitious national AI strategy, combining a $1B investment with a push for sovereign compute to reshape its economic future.

New real-world data on PEDMARK® suggests a breakthrough in preventing cisplatin-induced hearing loss for adults, a major step in cancer survivorship.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

Cannabis giant Green Thumb Industries expands its credit facility to $189M, signaling strong lender confidence and fueling its strategic growth ambitions.

A NJ practice is targeting the hidden crisis of eating disorders in men and athletes, offering specialized virtual care to break down stigma and access barriers.

After 65 years, Generac is a finalist for Wisconsin's top manufacturing award, lauded for its tech innovation, economic impact, and community investment.

The chemical giant's dramatic dividend cut ends a 14-year growth streak, raising questions about sector health and long-term investor returns.

The credit enhancement giant raises its quarterly payout, reflecting robust profitability, strategic growth, and strong confidence from Wall Street analysts.

A new stamp-sized oral film could replace the dreaded epinephrine needle. Aquestive's Anaphylm shows promise, but faces regulatory and market hurdles.

The biotech firm landed $1M at a premium, a sign of investor faith. But with past regulatory hurdles, can this cash pave a new path for its NurOwn® therapy?